350 related articles for article (PubMed ID: 30394318)
1. Pseudoginsenoside-F11 alleviates cognitive deficits and Alzheimer's disease-type pathologies in SAMP8 mice.
Zhang Z; Yang J; Liu C; Xie J; Qiu S; Yang X; Wu C
Pharmacol Res; 2019 Jan; 139():512-523. PubMed ID: 30394318
[TBL] [Abstract][Full Text] [Related]
2. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
3. Natural silibinin modulates amyloid precursor protein processing and amyloid-β protein clearance in APP/PS1 mice.
Bai D; Jin G; Zhang D; Zhao L; Wang M; Zhu Q; Zhu L; Sun Y; Liu X; Chen X; Zhang L; Li W; Cui Y
J Physiol Sci; 2019 Jul; 69(4):643-652. PubMed ID: 31087219
[TBL] [Abstract][Full Text] [Related]
4. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
Devi L; Ohno M
Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
[TBL] [Abstract][Full Text] [Related]
5. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
6. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
7. Total ginsenosides decrease Aβ production through activating PPARγ.
He S; Shi J; Ma L; Pei H; Zhang P; Shi D; Li H
Biomed Pharmacother; 2024 May; 174():116577. PubMed ID: 38593704
[TBL] [Abstract][Full Text] [Related]
8. Propranolol restores cognitive deficits and improves amyloid and Tau pathologies in a senescence-accelerated mouse model.
Dobarro M; Orejana L; Aguirre N; Ramírez MJ
Neuropharmacology; 2013 Jan; 64():137-44. PubMed ID: 22824191
[TBL] [Abstract][Full Text] [Related]
9. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro.
Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P
Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776
[TBL] [Abstract][Full Text] [Related]
10. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids facilitate astrocytic amyloid-β peptide deposition by increasing the expression of APP and BACE1 and decreasing the expression of amyloid-β-degrading proteases.
Wang Y; Li M; Tang J; Song M; Xu X; Xiong J; Li J; Bai Y
Endocrinology; 2011 Jul; 152(7):2704-15. PubMed ID: 21558319
[TBL] [Abstract][Full Text] [Related]
12. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.
Poon HF; Joshi G; Sultana R; Farr SA; Banks WA; Morley JE; Calabrese V; Butterfield DA
Brain Res; 2004 Aug; 1018(1):86-96. PubMed ID: 15262209
[TBL] [Abstract][Full Text] [Related]
13. Salvianolic acid B ameliorates retinal deficits in an early-stage Alzheimer's disease mouse model through downregulating BACE1 and Aβ generation.
Wang MD; Zhang S; Liu XY; Wang PP; Zhu YF; Zhu JR; Lv CS; Li SY; Liu SF; Wen L
Acta Pharmacol Sin; 2023 Nov; 44(11):2151-2168. PubMed ID: 37420104
[TBL] [Abstract][Full Text] [Related]
14. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
[TBL] [Abstract][Full Text] [Related]
15. Asthma aggravates alzheimer's disease by up-regulating NF- κB signaling pathway through LTD4.
Wang X; Gan W; Kang M; Lv C; Zhao Z; Wu Y; Zhang X; Wang R
Brain Res; 2024 Feb; 1825():148711. PubMed ID: 38092296
[TBL] [Abstract][Full Text] [Related]
16. RTN4B-mediated suppression of Sirtuin 2 activity ameliorates β-amyloid pathology and cognitive impairment in Alzheimer's disease mouse model.
Wang Y; Yang JQ; Hong TT; Sun YH; Huang HL; Chen F; Chen XJ; Chen HY; Dong SS; Cui LL; Yang TL
Aging Cell; 2020 Aug; 19(8):e13194. PubMed ID: 32700357
[TBL] [Abstract][Full Text] [Related]
17. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
18. Echinacoside Improves Cognitive Impairment by Inhibiting Aβ Deposition Through the PI3K/AKT/Nrf2/PPARγ Signaling Pathways in APP/PS1 Mice.
Qiu H; Liu X
Mol Neurobiol; 2022 Aug; 59(8):4987-4999. PubMed ID: 35665898
[TBL] [Abstract][Full Text] [Related]
19. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
Wiley JC; Pettan-Brewer C; Ladiges WC
Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer's disease mouse model by regulating the expression of APP secretases.
Zhang M; Wang W; Ye Q; Fu Y; Li X; Yang K; Gao F; Zhou A; Wei Y; Tian S; Li S; Wei F; Shi W; Li WD
Alzheimers Res Ther; 2024 Jan; 16(1):15. PubMed ID: 38245771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
